We are live on ! Find out more
BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

12 hedge funds and large institutions have $5.25M invested in Bristol-Myers Squibb Company Contingent Value Rights in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 529 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

98% less funds holding

Funds holding: 546 → 12 (-534)

98% less capital invested

Capital invested by funds: $338M → $5.25M (-$333M)

100% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 529

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

Holders
12
Holders Change
-534
Holders Change %
-97.8%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
529
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
JCI
Jet Capital Investors
New York
+$2.15M
2
TNB
Thomasville National Bank
Georgia
+$146K

Top Sellers

1
PCM
Pentwater Capital Management
Florida
-$47.7M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$20.6M
3
ACM
Abrams Capital Management
Massachusetts
-$17.1M
4
FCM
Farallon Capital Management
California
-$14.8M
5
BFS
Bard Financial Services
Connecticut
-$13.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
GSBTD
276
Glenview State Bank Trust Department
Illinois
– -$12K -16,790 Closed
IHL
277
Investment House LLC
California
– -$11K -16,539 Closed
KC
278
Kellner Capital
New York
– -$11K -16,300 Closed
ARMC
279
American Research & Management Company
Massachusetts
– -$11K -15,915 Closed
Manulife (Manufacturers Life Insurance)
280
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$11K -15,751 Closed
VVP
281
Venture Visionary Partners
Ohio
– -$10K -15,629 Closed
OFG
282
Oxford Financial Group
Indiana
– -$11K -15,538 Closed
APSP
283
Asset Planning Services (Pennsylvania)
Pennsylvania
– -$11K -15,421 Closed
RPC
284
Rossmore Private Capital
Connecticut
– -$11K -15,222 Closed
SACTSONJ
285
Supplemental Annuity Collective Trust (SACT) of New Jersey
New Jersey
– -$10K -15,000 Closed
ODG
286
O'Dell Group
Ohio
– -$10K -14,878 Closed
Dimensional Fund Advisors
287
Dimensional Fund Advisors
Texas
– -$10K -14,681 Closed
BFA
288
Beaumont Financial Advisors
Massachusetts
– -$10K -14,603 Closed
LCP
289
Legacy Capital Partners
Wisconsin
– -$10K -14,367 Closed
CAPTRUST Financial Advisors
290
CAPTRUST Financial Advisors
North Carolina
– -$10K -14,293 Closed
ISL
291
Ingalls & Snyder LLC
New York
– -$10K -14,250 Closed
CBT
292
Central Bank & Trust
Kentucky
– -$10K -14,117 Closed
YIA
293
YHB Investment Advisors
Connecticut
– -$10K -13,819 Closed
PAM
294
Panagora Asset Management
Massachusetts
– -$9K -13,744 Closed
IFG
295
Independent Financial Group
California
– -$9.48K -13,738 Closed
CCMG
296
Clark Capital Management Group
Pennsylvania
– -$9K -13,735 Closed
OC
297
Oakworth Capital
Alabama
– -$9K -13,535 Closed
DC
298
Diametric Capital
Massachusetts
– -$9K -13,216 Closed
WIM
299
Westside Investment Management
California
– -$9 -13,047 Closed
HT
300
Heritage Trust
Oklahoma
– -$9K -13,014 Closed
10 11
12
13 14

BMY.RT Hedge Fund Activity: Q1 2021 in Review

12 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) for Q1 2021, worth a combined $5.25M — down 98% from $338M a quarter earlier.

Sellers outnumbered buyers: 529 funds closed out of BMY.RT and 2 opened new positions — a net loss of 527 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Jet Capital Investors, adding an estimated $2.15M. The largest seller was Pentwater Capital Management, exiting entirely with an estimated $47.7M sold.

  • 12 institutional investors held Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) as of Q1 2021, down from 546 in Q4 2020.
  • Funds reported $5.25M of Bristol-Myers Squibb Company Contingent Value Rights stock for Q1 2021, down 98% quarter-over-quarter.
  • 2 funds opened new Bristol-Myers Squibb Company Contingent Value Rights positions in Q1 2021 and 529 closed out, a net change of -527 holders.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights buyer in Q1 2021 was Jet Capital Investors, an estimated $2.15M added.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights seller in Q1 2021 was Pentwater Capital Management, an estimated $47.7M sold.

Based on aggregated 13F filings for Q1 2021.